Latest news
LGND SWOT Analysis: Strong Revenue Growth Amidst Valuation Concerns Revealed in 10-Q Filing - GuruFocusGuruFocus · Sat, 08 Aug 2026 06:06:18 GMTCraig-Hallum Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Announces Target Price $370 - MoomooMoomoo · Sat, 08 Aug 2026 04:00:52 GMTLigand Pharmaceuticals Incorporated (LGND) stock price, news, quote and history - Yahoo Finance AustraliaYahoo Finance Australia · Fri, 07 Aug 2026 22:24:14 GMTLigand Pharmaceuticals (LGND) Releases Q2 2026 Earnings: Revenue Declines but EPS Jumps - Quiver QuantitativeQuiver Quantitative · Fri, 07 Aug 2026 20:39:00 GMTLGND Maintained by RBC Capital -- Price Target Raised to $345 - GuruFocusGuruFocus · Fri, 07 Aug 2026 20:24:12 GMTLGND Aug 2026 165.000 put (LGND260821P00165000) stock historical prices and data - Yahoo Finance AustraliaYahoo Finance Australia · Fri, 07 Aug 2026 13:41:47 GMTTVTX, LGND Stocks In Spotlight Ahead Of Monday’s FDA Call On Kidney Drug Filspari - StocktwitsStocktwits · Fri, 07 Aug 2026 09:03:29 GMTLigand Pharmaceuticals (LGND) Posts Strong Q2 Results, Is The Upside Already Priced In? - simplywall.stsimplywall.st · Fri, 07 Aug 2026 07:46:55 GMT